ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Bendamustine Hydrochloride Injection, Solution shortage

To Be Discontinued  1 presentations · 1 manufacturers · first FDA posting 2026-07-23 · last update 2026-07-23

Manufacturers: Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08)Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)To Be Discontinued
 —A business decision has been made to discontinue manufacture of the drug.Posted 07/23/2026
Updated 07/23/2026
Discontinued 07/23/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)